129 related articles for article (PubMed ID: 34397724)
1. Clinical value of CD97 and CD55 levels in the differential diagnosis of tuberculous and malignant pleural effusions.
Wang C; Jie J; Li D; Liu Y; Gao J; Song L
Medicine (Baltimore); 2021 Jul; 100(30):e26771. PubMed ID: 34397724
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
Gao J; Song L; Li D; Peng L; Ding H
Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
Al-Aarag AH; Kamel MH; Abdelgawad ER; Abo-Youssef SM; Moussa HH; Elnaggar ME; Hendy RM; Diab KA
BMC Pulm Med; 2019 Jun; 19(1):114. PubMed ID: 31238901
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
[TBL] [Abstract][Full Text] [Related]
5. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
7. IL-33 levels differentiate tuberculous pleurisy from malignant pleural effusions.
Xuan WX; Zhang JC; Zhou Q; Yang WB; Ma LJ
Oncol Lett; 2014 Jul; 8(1):449-453. PubMed ID: 24959294
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of superoxide dismutase in tuberculous and malignant pleural effusions.
Wang XF; Wu YH; Jiao J; Guan CP; Yang XG; Wang MS
Asian Pac J Cancer Prev; 2013; 14(2):821-4. PubMed ID: 23621245
[TBL] [Abstract][Full Text] [Related]
9. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1543-6. PubMed ID: 25146741
[TBL] [Abstract][Full Text] [Related]
10. A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion.
Liu Y; Ou Q; Zheng J; Shen L; Zhang B; Weng X; Shao L; Gao Y; Zhang W
Emerg Microbes Infect; 2016 Aug; 5(8):e83. PubMed ID: 27485497
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of Interleukin-27 between Tuberculous Pleural Effusion and Malignant Pleural Effusion: A Meta-Analysis.
Liu Q; Yu YX; Wang XJ; Wang Z; Wang Z
Respiration; 2018; 95(6):469-477. PubMed ID: 29539604
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.
Kim CH; Oh HG; Lee SY; Lim JK; Lee YH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Lee J
Ann Transl Med; 2019 Aug; 7(16):373. PubMed ID: 31555687
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interleukin-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion.
Li M; Wang H; Wang X; Huang J; Wang J; Xi X
J Cardiothorac Surg; 2014 Jul; 9():118. PubMed ID: 24984978
[TBL] [Abstract][Full Text] [Related]
14. Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
Yildiz PB; Yazar EE; Gorgun D; Secik F; Cakir G
Asian Pac J Cancer Prev; 2011; 12(2):419-23. PubMed ID: 21545206
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.
Bunjhoo H; Wang ZY; Chen HL; Cheng S; Xiong WN; Xu YJ; Cao Y
Asian Pac J Cancer Prev; 2012; 13(7):3495-9. PubMed ID: 22994784
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs.
Niu M; Xu S; Yang J; Yao D; Li N; Yan J; Zhong G; Song G
J Biol Chem; 2021; 296():100776. PubMed ID: 33992645
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
Wang M; Zhang Z; Wang X
Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
[TBL] [Abstract][Full Text] [Related]
18. Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion.
Ai L; Li J; Ye T; Wang W; Li Y
Dis Markers; 2022; 2022():5653033. PubMed ID: 35531478
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors and Treatment Outcomes of Tuberculous Pleural Effusion in Patients With Cancer and Pleural Effusion.
Lee J; Lee YD; Lim JK; Lee DH; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Am J Med Sci; 2017 Aug; 354(2):125-130. PubMed ID: 28864369
[TBL] [Abstract][Full Text] [Related]
20. The comparison of pleural fluid TNF-alpha and IL-10 levels with ADA in tuberculous pleural effusion.
Ciledag A; Kaya A; Erol S; Sen E; Celik G; Cesur S; Fidan Y; Kinikli S
Curr Med Chem; 2010; 17(19):2096-100. PubMed ID: 20423308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
